As per our report, the global proteomics market size is estimated to grow USD 34.21 billion by 2026 from USD 19.57 billion in 2021 and is projected to grow at a Compound Annual Growth Rate (CAGR) of 11.82 % during the forecast period.
This market research report on the global proteomics market deals with proteomics which is a study of proteomes. A proteome is defined as a group of proteins produced in any biological context. Proteomics is used to investigate where and when the proteins are expressed, the rate at which proteins are produced, degraded, and how proteins are modified. It is also used to find which proteins are the cause of cancer and various other biological problems.
Y-O-Y growth in the prevalence of cancer worldwide, the use of proteomics to research cancer genes, and protein interactions in cancer genes are expected to drive the global proteomics market growth.
Additionally, factors such as application of proteomics in the diagnosis of infectious diseases, technological advancement, increase in health care expenditure, rise in awareness, rising prevalence of cancer and associated genetic disorders, increasing funding for proteomics projects, birth disorders, the demand for customized medication, increased research and development programs, and increased biotech expenditure attributing to coronavirus outbreak drives the global proteomics market growth. Therefore, the global proteomics market is expected to expand dramatically in the coming years due to technological advancements, increased research funding, growing healthcare spending, rising demand for customized medicine, and the prevalence of genetic diseases.
The growing adoption of nano-proteomics is a lucrative opportunity in the proteomics market. In the field, nanotechnology assists in studying post-translational modifications (PTM), a wide range of molecules, and the complexities of biology. As a result, the nanoproteomics area has exploded in popularity due to the use of nanostructure surfaces to isolate proteins, phosphoproteomics/metal-oxide nanoparticles, and analytical recognition of biomarker proteins. Furthermore, rising proteomics adoption in emerging economies such as China, India, and others would open new markets for the proteomics market.
Stringent government regulations, high cost of the medicines and devices, lack of professional researchers, higher cost of research and development, inadequate funding, and lack of awareness regarding the application of proteomics in developing countries are likely to restrain the global proteomics market growth to a small extent. Additionally, factors such as sequestration cuts in the U.S. & reduced funds for proteomics research, a huge disconnect between biomarker discovery & biomarker approval by regulatory authorities, expensive tools and instruments & their maintenance, reduction in free trade are expected to challenge the market during the forecast period.
Impact of COVID-19 on the global proteomics market:
The emergence of covid-19 was started in Wuhan, China. The global pandemic has affected almost all sectors of the economy. Nearly 180 countries across the globe are dealing with the pandemic. Major sectors of the economy had been negatively affected during the first half 0f 2020. In the future, this pandemic is likely to provide growth prospects. Understanding the function of proteins in the SARS-CoV-2 infection process and COVID-19 progression is critical for developing therapeutic and preventative measures. One- and two-dimensional gel electrophoresis and high-performance liquid chromatography are two of the most popular separation procedures. Mass spectrometry (MS), on the other hand, is the backbone of protein detection and identification. Other proteomic approaches (such as 2D gel-electrophoresis) that need a significant amount of pure protein for analysis have been overcome by protein identification utilizing MS methods. In addition, virus proteins that influence respiratory pathways have previously been profiled using MS-based viral peptide detection. The predominant technique for detecting viral genes in COVID-19-positive individuals is reverse transcription-polymerase chain reaction (RT-PCR). However, due to SARS-high CoV-2's mutability, RT-PCR may not be sensitive enough to identify these genes.
Furthermore, due to its high reaction times, the method has limited throughput. On the other hand, MS-based detection can enable quick and straightforward identification of SARS-CoV-2, even in recovered patients. As a result, in the eyes of COVID-19, proteomics can aid in the discovery of novel biomarkers and the definition of point-of-care procedures, potentially allowing for more cost-effective healthcare to be given closer to the patient.
Market Size Available
2020 to 2026
2021 to 2026
By Waste, End-User, and Region
Various Analyses Covered
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
North America, Europe, Asia Pacific, Latin America, Middle East, and Africa
This research report on the global proteomics market has been segmented and sub-segmented based on the waste, end-user, and region.
Proteomics Market - By Instrument Type:
The protein microarray segment is expected to account for the highest proteomics market share during the forecast period based on the instrument type. It takes only a limited sample to produce multiple findings. Full protein imprinting, label-free identification, and total and direct quantification are also benefitting this technology. Protein fractionation is expected to expand at the highest rate in the near future due to its high resolution and efficient isolation of different proteins in a complex structure it provides.
Proteomics Market - By Reagents:
By 2025, the immunoassay reagents segment is predicted to account for the vast majority of the proteomics market share. The large share of this category is due to the availability of a wide range of reagents and the need for accurate, precise, and rapid disease detection at an early stage. In addition, protein fractionation reagents are expected to grow at the fastest rate in the proteomics market. This is because they help simplify the study of complex protein structures, making research faster and more efficient.
Proteomics Market - By Software & Service:
Due to the effectiveness of anatomical laboratory services in the diagnosis and drug discovery, the anatomical laboratory services segment is expected to hold a significant share of the market during the forecast period.
Proteomics Market - By Application:
Based on application, the Clinical Diagnostics segment accounted for the largest share in 2019 due to the increased understanding of protein expression structures for drug development and diseases.
The drug discovery segment is expected to grow at the highest CAGR due to a continuous search for efficient ways to deliver enhanced drugs.
Proteomics Market - By Region:
Regionally, North America dominated the global proteomics market in 2019 due to advanced research facilities' availability. Increased government spending, increased research efforts, high awareness of proteomics applications, strengthened health care facilities, high health care spending, and rising cancer incidence in the area are all factors driving market growth in North America. On the other hand, due to an increase in cancer research activities, high government support, and the presence of key market players in the region, Europe is expected to be the second leading market for proteomics during the forecast period.
However, decreasing funds in key markets like North America and Europe, sequestration cuts in the U.S. and reduced assets for proteomics research, the high cost of instruments and hardware, and lack of talented scientists are some of the major factors restraining the global proteomics market.
Asia-pacific is expected to increase at the highest CAGR due to the improving medical infrastructure, the growing influence of key players, and developing economies. In recent years, the economy of Asia has exponentially increased; this has to lead to potential new customers for the healthcare industry. Due to the effects of China's one-child policy, now a young couple needs to look after four sets of parents and many grandparents. This rise in the elderly population is projected to drive the industry, like the medical needs of the elderly are more pronounced than the younger folk. A similar problem is also being experienced in many European nations and countries like Japan. Proteomics gives an idea of what exactly is going on in the body at any state. It is like the forensics of living tissue. This helps physicians understand in greater detail the problems plaguing the patient and devise a better treatment protocol. The study also allows researchers to design better drugs as the detailed molecular picture can be accessed by looking at the proteomes. Thus, the increasing requirement for customized medicine, R&D use, technological advancements, and increased financing for proteomics ventures are some of the factors driving the global proteomics market.
KEY MARKET PARTICIPANTS:
Companies leading the global proteomics market profiled in the report are Agilent Technologies Inc., Bio-Rad Laboratories, Inc., Bruker Corporation, Danaher Corporation, GE Healthcare, Luminex Corporation, Merck KGaA, PerkinElmer Inc., Thermo Fisher Scientific, Inc. and Waters Corporation.
Agilent Technologies Inc. is an American company that was established in 1999 as a spin-off of Hewlett Packard. It’s a public research, development, and manufacturing company. When the IPO for the company was released, it was the largest in Silicon Valley at that time. It is headquartered in Santa Clara, California, has more than 13,500 employees as of 2017, and reported net revenue of USD 4.5 billion in that year.
RECENT MARKET HAPPENINGS:
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Protein Microarrays
5.1.4 X-ray crystallography
5.1.7 Surface Plasmon Resonance
5.1.8 protein fractionation
5.1.5 Y-o-Y Growth Analysis, By Instrument
5.1.6 Market Attractiveness Analysis, By Instrument
5.1.7 Market Share Analysis, By Instrument
5.2.2 Protein Microarray Reagents
5.2.3 X-Ray Crystallography Reagents
5.2.4 Spectroscopy Reagents
5.2.5 Chromatography Reagents
5.2.6 Electrophoresis Reagents
5.2.7 Immunoassay Reagents
5.2.8 Protein Fractionation Reagent
5.2.9 Y-o-Y Growth Analysis, By Reagent
5.2.10 Market Attractiveness Analysis, By Reagent
5.2.11 Market Share Analysis, By Reagent
5.3 Service & Software
5.3.2 Analytical Laboratory Services
5.3.3 Data Analysis & Maintenanc
5.3.4 Quantitation Services
5.3.5 Y-o-Y Growth Analysis, By Service & Software
5.3.6 Market Attractiveness Analysis, By Service & Software
5.3.7 Market Share Analysis, By Service & Software
5.4.3 Drug Discovery
5.4.4 other proteomic Application
5.4.5 Y-o-Y Growth Analysis, By Application
5.4.8 Market Attractiveness Analysis, By Application
5.4.9 Market Share Analysis, By Application
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.4 Market Attractiveness Analysis
6.1.5 Market Share Analysis
6.2 North America
6.1.2 United States
6.3.6 South Korea
6.5 Latin America
6.4.5 Rest of Latin America
6.6 Middle East & Africa
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Agilent Technologies Inc
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Bio-Rad Laboratories, Inc.
8.3 Bruker Corporation
8.4 Danaher Corporation
8.5 GE Healthcare
8.6 Luminex Corporation
8.7 Merck KGaA
8.8 PerkinElmer Inc.
8.9 Thermo Fisher Scientific, Inc.
8.10 Waters Corporation
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures